… in AD and that several drugs enhancing 5-HT neurotransmission are … of the role of serotonergic
neurotransmission in brain … serotonergic transmission in neurological diseases and AD. …

… and psychotic symptoms in Alzheimer’s disease. Starting from … serotonergic subreceptors
in the involved brain regions. Results: In the hippocampus and prefrontal cortex, serotonin …

… in almost 90% of patients with Alzheimer's Disease (AD), cause extensive impairment …
systems are capable of inducing psychosis, these are “dirty drugs” that activate a number of …

… drugs target GPCRs and some already target serotonin receptors. Several of these serotonergic
… A critical overview of therapeutic strategy and advancement for Alzheimer's disease …

… Some of the serotonergic drugs described in this review seem to be promising therapies …
some disease-modifying actions. However, when analysing the effectiveness of a new drug, …

… drugs, targeting alternative neurotransmitter pathways, particularly those targeting serotonergic
(… In this review, we focused on 5-HT receptor (5-HTR) mediated signalling and drugs that …

… serotonergic denervation. Values for serotonergic markers in Alzheimer’s disease sam- …
of serotonergic drugs on glutamatergic neurones may provide a novel therapeutic approach …

… agents in Alzheimer's patients since the … serotonin (T)-HT) lesion in AD. and discusses
how this deficit may contribute to the cognitive and noncognitive symptoms of Alzheimer's …

… serotonin 6 receptor is attracting attention as an etiological contributor in cognition deficits in
diseases such as Alzheimer’s disease… memory, particularly in Alzheimer’s disease. A surge …

… stimulation in non-AD subjects mainly shows effects on DMN connectivity, and DMN
coherence is most often found to be altered in AD, we examined drug effects on DMN connectivity …